1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 PCR 1.2.3 NGS 1.2.4 ELISA or EIA 1.2.5 IHC 1.2.6 ISH 1.2.7 Others 1.3 Market by Application 1.3.1 Global Infectious Disease Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals and Clinics 1.3.3 Diagnostic Centers 1.3.4 Academic Research Institutes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Infectious Disease Biomarker Testing Market Perspective (2016-2027) 2.2 Infectious Disease Biomarker Testing Growth Trends by Regions 2.2.1 Infectious Disease Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Infectious Disease Biomarker Testing Historic Market Share by Regions (2016-2021) 2.2.3 Infectious Disease Biomarker Testing Forecasted Market Size by Regions (2022-2027) 2.3 Infectious Disease Biomarker Testing Industry Dynamic 2.3.1 Infectious Disease Biomarker Testing Market Trends 2.3.2 Infectious Disease Biomarker Testing Market Drivers 2.3.3 Infectious Disease Biomarker Testing Market Challenges 2.3.4 Infectious Disease Biomarker Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Infectious Disease Biomarker Testing Players by Revenue 3.1.1 Global Top Infectious Disease Biomarker Testing Players by Revenue (2016-2021) 3.1.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Players (2016-2021) 3.2 Global Infectious Disease Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Infectious Disease Biomarker Testing Revenue 3.4 Global Infectious Disease Biomarker Testing Market Concentration Ratio 3.4.1 Global Infectious Disease Biomarker Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Biomarker Testing Revenue in 2020 3.5 Infectious Disease Biomarker Testing Key Players Head office and Area Served 3.6 Key Players Infectious Disease Biomarker Testing Product Solution and Service 3.7 Date of Enter into Infectious Disease Biomarker Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Infectious Disease Biomarker Testing Breakdown Data by Type 4.1 Global Infectious Disease Biomarker Testing Historic Market Size by Type (2016-2021) 4.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2022-2027) 5 Infectious Disease Biomarker Testing Breakdown Data by Application 5.1 Global Infectious Disease Biomarker Testing Historic Market Size by Application (2016-2021) 5.2 Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Infectious Disease Biomarker Testing Market Size (2016-2027) 6.2 North America Infectious Disease Biomarker Testing Market Size by Type 6.2.1 North America Infectious Disease Biomarker Testing Market Size by Type (2016-2021) 6.2.2 North America Infectious Disease Biomarker Testing Market Size by Type (2022-2027) 6.2.3 North America Infectious Disease Biomarker Testing Market Size by Type (2016-2027) 6.3 North America Infectious Disease Biomarker Testing Market Size by Application 6.3.1 North America Infectious Disease Biomarker Testing Market Size by Application (2016-2021) 6.3.2 North America Infectious Disease Biomarker Testing Market Size by Application (2022-2027) 6.3.3 North America Infectious Disease Biomarker Testing Market Size by Application (2016-2027) 6.4 North America Infectious Disease Biomarker Testing Market Size by Country 6.4.1 North America Infectious Disease Biomarker Testing Market Size by Country (2016-2021) 6.4.2 North America Infectious Disease Biomarker Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Infectious Disease Biomarker Testing Market Size (2016-2027) 7.2 Europe Infectious Disease Biomarker Testing Market Size by Type 7.2.1 Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2021) 7.2.2 Europe Infectious Disease Biomarker Testing Market Size by Type (2022-2027) 7.2.3 Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2027) 7.3 Europe Infectious Disease Biomarker Testing Market Size by Application 7.3.1 Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2021) 7.3.2 Europe Infectious Disease Biomarker Testing Market Size by Application (2022-2027) 7.3.3 Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2027) 7.4 Europe Infectious Disease Biomarker Testing Market Size by Country 7.4.1 Europe Infectious Disease Biomarker Testing Market Size by Country (2016-2021) 7.4.2 Europe Infectious Disease Biomarker Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size (2016-2027) 8.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type 8.2.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2016-2027) 8.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application 8.3.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region 8.4.1 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Infectious Disease Biomarker Testing Market Size (2016-2027) 9.2 Latin America Infectious Disease Biomarker Testing Market Size by Type 9.2.1 Latin America Infectious Disease Biomarker Testing Market Size by Type (2016-2021) 9.2.2 Latin America Infectious Disease Biomarker Testing Market Size by Type (2022-2027) 9.2.3 Latin America Infectious Disease Biomarker Testing Market Size by Type (2016-2027) 9.3 Latin America Infectious Disease Biomarker Testing Market Size by Application 9.3.1 Latin America Infectious Disease Biomarker Testing Market Size by Application (2016-2021) 9.3.2 Latin America Infectious Disease Biomarker Testing Market Size by Application (2022-2027) 9.3.3 Latin America Infectious Disease Biomarker Testing Market Size by Application (2016-2027) 9.4 Latin America Infectious Disease Biomarker Testing Market Size by Country 9.4.1 Latin America Infectious Disease Biomarker Testing Market Size by Country (2016-2021) 9.4.2 Latin America Infectious Disease Biomarker Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size (2016-2027) 10.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type 10.2.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2027) 10.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application 10.3.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country 10.4.1 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abacus Diagnostica 11.1.1 Abacus Diagnostica Company Details 11.1.2 Abacus Diagnostica Business Overview 11.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Introduction 11.1.4 Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.1.5 Abacus Diagnostica Recent Development 11.2 ALPCO 11.2.1 ALPCO Company Details 11.2.2 ALPCO Business Overview 11.2.3 ALPCO Infectious Disease Biomarker Testing Introduction 11.2.4 ALPCO Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.2.5 ALPCO Recent Development 11.3 Abbott Laboratories 11.3.1 Abbott Laboratories Company Details 11.3.2 Abbott Laboratories Business Overview 11.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Introduction 11.3.4 Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.3.5 Abbott Laboratories Recent Development 11.4 Agilent Technologies 11.4.1 Agilent Technologies Company Details 11.4.2 Agilent Technologies Business Overview 11.4.3 Agilent Technologies Infectious Disease Biomarker Testing Introduction 11.4.4 Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.4.5 Agilent Technologies Recent Development 11.5 Becton 11.5.1 Becton Company Details 11.5.2 Becton Business Overview 11.5.3 Becton Infectious Disease Biomarker Testing Introduction 11.5.4 Becton Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.5.5 Becton Recent Development 11.6 Dickinson and Company 11.6.1 Dickinson and Company Company Details 11.6.2 Dickinson and Company Business Overview 11.6.3 Dickinson and Company Infectious Disease Biomarker Testing Introduction 11.6.4 Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.6.5 Dickinson and Company Recent Development 11.7 bioMérieux SA 11.7.1 bioMérieux SA Company Details 11.7.2 bioMérieux SA Business Overview 11.7.3 bioMérieux SA Infectious Disease Biomarker Testing Introduction 11.7.4 bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.7.5 bioMérieux SA Recent Development 11.8 Bio-Rad Laboratories 11.8.1 Bio-Rad Laboratories Company Details 11.8.2 Bio-Rad Laboratories Business Overview 11.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Introduction 11.8.4 Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.8.5 Bio-Rad Laboratories Recent Development 11.9 Danaher 11.9.1 Danaher Company Details 11.9.2 Danaher Business Overview 11.9.3 Danaher Infectious Disease Biomarker Testing Introduction 11.9.4 Danaher Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.9.5 Danaher Recent Development 11.10 F. Hoffmann-La Roche 11.10.1 F. Hoffmann-La Roche Company Details 11.10.2 F. Hoffmann-La Roche Business Overview 11.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Introduction 11.10.4 F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.10.5 F. Hoffmann-La Roche Recent Development 11.11 Hologic 11.11.1 Hologic Company Details 11.11.2 Hologic Business Overview 11.11.3 Hologic Infectious Disease Biomarker Testing Introduction 11.11.4 Hologic Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.11.5 Hologic Recent Development 11.12 PerkinElmer 11.12.1 PerkinElmer Company Details 11.12.2 PerkinElmer Business Overview 11.12.3 PerkinElmer Infectious Disease Biomarker Testing Introduction 11.12.4 PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.12.5 PerkinElmer Recent Development 11.13 Qiagen 11.13.1 Qiagen Company Details 11.13.2 Qiagen Business Overview 11.13.3 Qiagen Infectious Disease Biomarker Testing Introduction 11.13.4 Qiagen Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.13.5 Qiagen Recent Development 11.14 Quest Diagnostics Incorporated 11.14.1 Quest Diagnostics Incorporated Company Details 11.14.2 Quest Diagnostics Incorporated Business Overview 11.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Introduction 11.14.4 Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.14.5 Quest Diagnostics Incorporated Recent Development 11.15 Siemens Healthineers 11.15.1 Siemens Healthineers Company Details 11.15.2 Siemens Healthineers Business Overview 11.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Introduction 11.15.4 Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.15.5 Siemens Healthineers Recent Development 11.16 Thermo Fisher Scientific 11.16.1 Thermo Fisher Scientific Company Details 11.16.2 Thermo Fisher Scientific Business Overview 11.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Introduction 11.16.4 Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2016-2021) 11.16.5 Thermo Fisher Scientific Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Infectious Disease Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of PCR Table 3. Key Players of NGS Table 4. Key Players of ELISA or EIA Table 5. Key Players of IHC Table 6. Key Players of ISH Table 7. Key Players of Others Table 8. Global Infectious Disease Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Infectious Disease Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Infectious Disease Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million) Table 11. Global Infectious Disease Biomarker Testing Market Share by Regions (2016-2021) Table 12. Global Infectious Disease Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 13. Global Infectious Disease Biomarker Testing Market Share by Regions (2022-2027) Table 14. Infectious Disease Biomarker Testing Market Trends Table 15. Infectious Disease Biomarker Testing Market Drivers Table 16. Infectious Disease Biomarker Testing Market Challenges Table 17. Infectious Disease Biomarker Testing Market Restraints Table 18. Global Infectious Disease Biomarker Testing Revenue by Players (2016-2021) & (US$ Million) Table 19. Global Infectious Disease Biomarker Testing Market Share by Players (2016-2021) Table 20. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Biomarker Testing as of 2020) Table 21. Ranking of Global Top Infectious Disease Biomarker Testing Companies by Revenue (US$ Million) in 2020 Table 22. Global 5 Largest Players Market Share by Infectious Disease Biomarker Testing Revenue (CR5 and HHI) & (2016-2021) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Infectious Disease Biomarker Testing Product Solution and Service Table 25. Date of Enter into Infectious Disease Biomarker Testing Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 28. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2016-2021) Table 29. Global Infectious Disease Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 30. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 31. Global Infectious Disease Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 32. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2016-2021) Table 33. Global Infectious Disease Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 34. Global Infectious Disease Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 35. North America Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 36. North America Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 37. North America Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 38. North America Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 39. North America Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 40. North America Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 41. Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 42. Europe Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 43. Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 44. Europe Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 45. Europe Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 46. Europe Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 47. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 48. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 49. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 50. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 51. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2016-2021) & (US$ Million) Table 52. Asia-Pacific Infectious Disease Biomarker Testing Market Size by Region (2022-2027) & (US$ Million) Table 53. Latin America Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 54. Latin America Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 55. Latin America Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 56. Latin America Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 57. Latin America Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 58. Latin America Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 59. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 60. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 61. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 62. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 63. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 64. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 65. Abacus Diagnostica Company Details Table 66. Abacus Diagnostica Business Overview Table 67. Abacus Diagnostica Infectious Disease Biomarker Testing Product Table 68. Abacus Diagnostica Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 69. Abacus Diagnostica Recent Development Table 70. ALPCO Company Details Table 71. ALPCO Business Overview Table 72. ALPCO Infectious Disease Biomarker Testing Product Table 73. ALPCO Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 74. ALPCO Recent Development Table 75. Abbott Laboratories Company Details Table 76. Abbott Laboratories Business Overview Table 77. Abbott Laboratories Infectious Disease Biomarker Testing Product Table 78. Abbott Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 79. Abbott Laboratories Recent Development Table 80. Agilent Technologies Company Details Table 81. Agilent Technologies Business Overview Table 82. Agilent Technologies Infectious Disease Biomarker Testing Product Table 83. Agilent Technologies Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 84. Agilent Technologies Recent Development Table 85. Becton Company Details Table 86. Becton Business Overview Table 87. Becton Infectious Disease Biomarker Testing Product Table 88. Becton Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 89. Becton Recent Development Table 90. Dickinson and Company Company Details Table 91. Dickinson and Company Business Overview Table 92. Dickinson and Company Infectious Disease Biomarker Testing Product Table 93. Dickinson and Company Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 94. Dickinson and Company Recent Development Table 95. bioMérieux SA Company Details Table 96. bioMérieux SA Business Overview Table 97. bioMérieux SA Infectious Disease Biomarker Testing Product Table 98. bioMérieux SA Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 99. bioMérieux SA Recent Development Table 100. Bio-Rad Laboratories Company Details Table 101. Bio-Rad Laboratories Business Overview Table 102. Bio-Rad Laboratories Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 103. Bio-Rad Laboratories Recent Development Table 104. Danaher Company Details Table 105. Danaher Business Overview Table 106. Danaher Infectious Disease Biomarker Testing Product Table 107. Danaher Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 108. Danaher Recent Development Table 109. F. Hoffmann-La Roche Company Details Table 110. F. Hoffmann-La Roche Business Overview Table 111. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Table 112. F. Hoffmann-La Roche Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 113. F. Hoffmann-La Roche Recent Development Table 114. Hologic Company Details Table 115. Hologic Business Overview Table 116. Hologic Infectious Disease Biomarker Testing Product Table 117. Hologic Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 118. Hologic Recent Development Table 119. PerkinElmer Company Details Table 120. PerkinElmer Business Overview Table 121. PerkinElmer Infectious Disease Biomarker Testing Product Table 122. PerkinElmer Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 123. PerkinElmer Recent Development Table 124. Qiagen Company Details Table 125. Qiagen Business Overview Table 126. Qiagen Infectious Disease Biomarker Testing Product Table 127. Qiagen Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 128. Qiagen Recent Development Table 129. Quest Diagnostics Incorporated Company Details Table 130. Quest Diagnostics Incorporated Business Overview Table 131. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Table 132. Quest Diagnostics Incorporated Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 133. Quest Diagnostics Incorporated Recent Development Table 134. Siemens Healthineers Company Details Table 135. Siemens Healthineers Business Overview Table 136. Siemens Healthineers Infectious Disease Biomarker Testing Product Table 137. Siemens Healthineers Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 138. Siemens Healthineers Recent Development Table 139. Thermo Fisher Scientific Company Details Table 140. Thermo Fisher Scientific Business Overview Table 141. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Table 142. Thermo Fisher Scientific Revenue in Infectious Disease Biomarker Testing Business (2016-2021) & (US$ Million) Table 143. Thermo Fisher Scientific Recent Development Table 144. Research Programs/Design for This Report Table 145. Key Data Information from Secondary Sources Table 146. Key Data Information from Primary Sources List of Figures Figure 1. Global Infectious Disease Biomarker Testing Market Share by Type: 2020 VS 2027 Figure 2. PCR Features Figure 3. NGS Features Figure 4. ELISA or EIA Features Figure 5. IHC Features Figure 6. ISH Features Figure 7. Others Features Figure 8. Global Infectious Disease Biomarker Testing Market Share by Application: 2020 VS 2027 Figure 9. Hospitals and Clinics Case Studies Figure 10. Diagnostic Centers Case Studies Figure 11. Academic Research Institutes Case Studies Figure 12. Others Case Studies Figure 13. Infectious Disease Biomarker Testing Report Years Considered Figure 14. Global Infectious Disease Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Infectious Disease Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Infectious Disease Biomarker Testing Market Share by Regions: 2020 VS 2027 Figure 17. Global Infectious Disease Biomarker Testing Market Share by Regions (2022-2027) Figure 18. Global Infectious Disease Biomarker Testing Market Share by Players in 2020 Figure 19. Global Top Infectious Disease Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Biomarker Testing as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Infectious Disease Biomarker Testing Revenue in 2020 Figure 21. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2016-2021) Figure 22. Global Infectious Disease Biomarker Testing Revenue Market Share by Type (2022-2027) Figure 23. North America Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Infectious Disease Biomarker Testing Market Share by Type (2016-2027) Figure 25. North America Infectious Disease Biomarker Testing Market Share by Application (2016-2027) Figure 26. North America Infectious Disease Biomarker Testing Market Share by Country (2016-2027) Figure 27. United States Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Infectious Disease Biomarker Testing Market Share by Type (2016-2027) Figure 31. Europe Infectious Disease Biomarker Testing Market Share by Application (2016-2027) Figure 32. Europe Infectious Disease Biomarker Testing Market Share by Country (2016-2027) Figure 33. Germany Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Type (2016-2027) Figure 41. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Application (2016-2027) Figure 42. Asia-Pacific Infectious Disease Biomarker Testing Market Share by Region (2016-2027) Figure 43. China Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Infectious Disease Biomarker Testing Market Share by Type (2016-2027) Figure 51. Latin America Infectious Disease Biomarker Testing Market Share by Application (2016-2027) Figure 52. Latin America Infectious Disease Biomarker Testing Market Share by Country (2016-2027) Figure 53. Mexico Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Type (2016-2027) Figure 57. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Application (2016-2027) Figure 58. Middle East & Africa Infectious Disease Biomarker Testing Market Share by Country (2016-2027) Figure 59. Turkey Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Infectious Disease Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Abacus Diagnostica Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 63. ALPCO Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 64. Abbott Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 65. Agilent Technologies Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 66. Becton Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 67. Dickinson and Company Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 68. bioMérieux SA Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 70. Danaher Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 71. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 72. Hologic Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 73. PerkinElmer Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 74. Qiagen Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 75. Quest Diagnostics Incorporated Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 76. Siemens Healthineers Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 77. Thermo Fisher Scientific Revenue Growth Rate in Infectious Disease Biomarker Testing Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Abacus Diagnostica ALPCO Abbott Laboratories Agilent Technologies Becton Dickinson and Company bioMérieux SA Bio-Rad Laboratories Danaher F. Hoffmann-La Roche Hologic PerkinElmer Qiagen Quest Diagnostics Incorporated Siemens Healthineers Thermo Fisher Scientific